Unique Crypto Strategies
  • Business
  • Politics
  • Investing
  • World
  • Business
  • Politics
  • Investing
  • World

Unique Crypto Strategies

Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by July 28, 2025
July 28, 2025
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com
0
FacebookTwitterGoogle +Pinterest
previous post
Maiden Drill Program Commences at Oasis Uranium Project
next post
Agreement to Develop New Expandable Graphite Facility

You may also like

Blackstone Merger to Acquire World Class Copper Gold...

Gold Reaches New Price Record, Then Pulls Back;...

Copper and Consequences: US Tariffs Stir Uncertainty in...

PEP11 Update Federal Court Judicial Review

Andy Schectman: BRICS, Trump and Gold — What...

Exceptional silver and cobalt assays from seaweed

Crypto Price Update: Q1 2025 in Review

Noble Minerals Announces Update to Drilling Results from...

LU7 to Raise $2.14M in Placement and Launch...

Highlights from NVIDIA’s GTC 2025 Keynote

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • Comet share sale and debt repayment

    • Agreement to Develop New Expandable Graphite Facility

    • RAD receives IND approval from US FDA for Betabart (RV-01)

    • Maiden Drill Program Commences at Oasis Uranium Project

    • Asara raises $25m to accelerate exploration at Kada

    Categories

    • Business (563)
    • Investing (2,851)
    • Politics (4,512)
    • Uncategorized (1)
    • World (2,735)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: uniquecryptostrategies.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 uniquecryptostrategies.com | All Rights Reserved


    Back To Top